Middle East and Africa PCR for Respiratory Infection Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens), and End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others)

No. of Pages: 213
Report Code: TIPRE00024252
Category: Life Sciences
Middle East and Africa PCR for Respiratory Infection Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Regional Analysis

6.2 Middle East and Africa PCR for Respiratory Infection Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa PCR for Respiratory Infection Diagnostics Market Forecast Analysis

7. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Analysis – by Type

7.1 Real-Time PCR
  • 7.1.1 Overview
  • 7.1.2 Real-Time PCR: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Multiplex PCR
  • 7.2.1 Overview
  • 7.2.2 Multiplex PCR: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Traditional PCR
  • 7.3.1 Overview
  • 7.3.2 Traditional PCR: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Digital PCR
  • 7.4.1 Overview
  • 7.4.2 Digital PCR: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Reverse-Transcriptase
  • 7.5.1 Overview
  • 7.5.2 Reverse-Transcriptase: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Analysis – by Product Type

8.1 Reagents & Kits
  • 8.1.1 Overview
  • 8.1.2 Reagents & Kits: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Instruments
  • 8.2.1 Overview
  • 8.2.2 Instruments: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Analysis – by Infection Type

9.1 Bacterial Infections
  • 9.1.1 Overview
  • 9.1.2 Bacterial Infections: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Viral Infections
  • 9.2.1 Overview
  • 9.2.2 Viral Infections: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Fungal & Other Pathogens
  • 9.3.1 Overview
  • 9.3.2 Fungal & Other Pathogens: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Middle East and Africa PCR for Respiratory Infection Diagnostics Market Analysis – by End User

10.1 Hospitals
  • 10.1.1 Overview
  • 10.1.2 Hospitals: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Physician Clinics
  • 10.2.1 Overview
  • 10.2.2 Physician Clinics: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Clinical Laboratories
  • 10.3.1 Overview
  • 10.3.2 Clinical Laboratories: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.4 Academic & Research Institutions
  • 10.4.1 Overview
  • 10.4.2 Academic & Research Institutions: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.5 Biotech & Pharma Companies
  • 10.5.1 Overview
  • 10.5.2 Biotech & Pharma Companies: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa
  • 11.2.1 Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 11.2.1.1 Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 South Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 South Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 11.2.1.1.2 South Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 11.2.1.1.3 South Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
    • 11.2.1.1.4 South Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
  • 11.2.1.2 Saudi Arabia: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Saudi Arabia: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 11.2.1.2.2 Saudi Arabia: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 11.2.1.2.3 Saudi Arabia: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
    • 11.2.1.2.4 Saudi Arabia: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
  • 11.2.1.3 UAE: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 UAE: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 11.2.1.3.2 UAE: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 11.2.1.3.3 UAE: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
    • 11.2.1.3.4 UAE: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
  • 11.2.1.4 Rest of Middle East and Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 11.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 11.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
    • 11.2.1.4.4 Rest of Middle East and Africa: Middle East and Africa PCR for Respiratory Infection Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Abbott
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Hologic, Inc.
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 BD
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 bioMerieux SA
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 QIAGEN
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Seegene Inc
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 AusDiagnostics
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Middle East and Africa PCR for Respiratory Infection Diagnostics Market

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD
  • Hologic, Inc.
  • BD
  • BIO-RAD LABORATORIES INC.
  • bioMerieux SA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Seegene Inc
  • AusDiagnostics
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)